Stockscreener 앱 받기
3.73
5.37%
0.19
시간 외 거래:
3.74
0.01
+0.27%
전일 마감가:
$3.54
열려 있는:
$3.54
하루 거래량:
1.64M
Relative Volume:
1.12
시가총액:
$367.71M
수익:
$775.09M
순이익/손실:
$-58.68M
주가수익비율:
-28.13
EPS:
-0.1326
순현금흐름:
$64.06M
1주 성능:
+7.49%
1개월 성능:
-21.47%
6개월 성능:
-25.99%
1년 성능:
-46.10%
1일 변동 폭
$3.54
$3.775
1주일 범위
$3.38
$3.775
52주 변동 폭
$3.305
$8.80
Goodrx Holdings Inc Stock (GDRX) Company Profile
명칭
Goodrx Holdings Inc
전화
(855) 268-2822
주소
2701 OLYMPIC BOULEVARD, SANTA MONICA
GDRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
3.73 | 1.23B | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
280.61 | 44.94B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
73.78 | 12.44B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
65.13 | 11.90B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.89 | 7.56B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.08 | 6.19B | 906.14M | -52.62M | 89.62M | -0.3621 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-08-09 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-05-23 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-05-16 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2024-04-10 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-03-25 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-03-01 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-02 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2023-08-10 | 업그레이드 | DA Davidson | Neutral → Buy |
| 2023-07-31 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2022-12-01 | 개시 | Citigroup | Buy |
| 2022-11-04 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-12 | 개시 | DA Davidson | Neutral |
| 2022-06-10 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-06-06 | 재개 | BofA Securities | Buy |
| 2022-06-01 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-05-10 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-05-10 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-05-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2022-05-10 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | 개시 | Wells Fargo | Equal Weight |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Neutral |
| 2022-03-15 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2022-03-01 | 재확인 | Barclays | Overweight |
| 2022-03-01 | 재확인 | BofA Securities | Neutral |
| 2022-03-01 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2022-03-01 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-03-01 | 재확인 | Evercore ISI | Outperform |
| 2022-03-01 | 재확인 | Goldman | Buy |
| 2022-03-01 | 재확인 | JP Morgan | Underweight |
| 2022-03-01 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-03-01 | 재확인 | SVB Leerink | Outperform |
| 2022-01-07 | 개시 | Goldman | Buy |
| 2021-12-21 | 개시 | Stephens | Overweight |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-08-31 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2021-08-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2021-05-28 | 개시 | Robert W. Baird | Neutral |
| 2021-04-06 | 재개 | Evercore ISI | Outperform |
| 2021-01-25 | 개시 | Guggenheim | Buy |
| 2020-11-19 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-19 | 개시 | Barclays | Equal Weight |
| 2020-10-19 | 개시 | BofA Securities | Neutral |
| 2020-10-19 | 개시 | Citigroup | Buy |
| 2020-10-19 | 개시 | Cowen | Outperform |
| 2020-10-19 | 개시 | Credit Suisse | Outperform |
| 2020-10-19 | 개시 | Deutsche Bank | Hold |
| 2020-10-19 | 개시 | Goldman | Neutral |
| 2020-10-19 | 개시 | JP Morgan | Neutral |
| 2020-10-19 | 개시 | Morgan Stanley | Overweight |
| 2020-10-19 | 개시 | RBC Capital Mkts | Sector Perform |
| 2020-10-19 | 개시 | SVB Leerink | Outperform |
| 2020-10-19 | 개시 | UBS | Buy |
모두보기
Goodrx Holdings Inc 주식(GDRX)의 최신 뉴스
Quant Strategy Flags GoodRx Holdings Inc. for Entry2025 Sector Review & Weekly High Potential Alerts - metal.it
GoodRx Holdings' (NASDAQ:GDRX) Performance Is Even Better Than Its Earnings Suggest - simplywall.st
Why Investors Shouldn't Be Surprised By GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 25% Share Price Plunge - 富途牛牛
GoodRx Earnings Call: Growth Amid Challenges - MSN
GoodRx Holdings Inc. Stock Poised for Technical ComebackJuly 2025 Rallies & Community Verified Swing Trade Signals - thegnnews.com
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q2 2025 Earnings Call Transcript - Insider Monkey
UBS Keeps Hold Rating on GoodRx Holdings with $4.25 Target - AInvest
GoodRx Q2 Earnings Miss Expectations Due to Rite Aid Bankruptcy and PBM Disruptions. - AInvest
GoodRx stock price target lowered to $4.25 from $5.25 at UBS - Investing.com Australia
GoodRx Holdings Inc. (GDRX) PT Lowered to $4.25 at UBS - StreetInsider
Deutsche Bank Adjusts GoodRx Price Target to $6 From $8, Maintains Hold Rating - MarketScreener
Raymond James Downgrades GoodRx Holdings to Outperform From Strong Buy, Adjusts Price Target to $5 From $9 - MarketScreener
GoodRx Holdings: Buy Rating Maintained Despite Short-term Adjustments - AInvest
GoodRx Holdings Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: GoodRx Holdings (GDRX) and Elanco Animal Health (ELAN) - The Globe and Mail
GoodRx Holdings Inc. stock chart pattern explainedVolume Confirmed Setup with Entry Confidence - Newser
Using AI based signals to follow GoodRx Holdings Inc.AI-Based Reversal Point Prediction Signal - Newser
Earnings visualization tools for GoodRx Holdings Inc.Weekly Market Direction and Sector Summary - Newser
How to integrate GoodRx Holdings Inc. into portfolio analysis toolsShort-Term AI-Based Stock Price Forecast - Newser
How GoodRx Holdings Inc. stock performs during market volatilityWealth Accumulation Outlook for Safe Investors - Newser
Statistical indicators supporting GoodRx Holdings Inc.’s strengthWeekly Return Plan for Conservative Traders - Newser
GoodRx downgraded to Outperform from Strong Buy at Raymond James - TipRanks
GoodRx stock downgraded by Raymond James on guidance cut after Rite Aid closures - Investing.com South Africa
Raymond James Downgrades GoodRx Holdings Inc. (GDRX) to Outperform - StreetInsider
Transcript : GoodRx Holdings, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
GoodRx stock falls as Morgan Stanley cuts price target on retail challenges By Investing.com - Investing.com South Africa
GoodRx stock falls as Morgan Stanley cuts price target on retail challenges - Investing.com Canada
Morgan Stanley Cuts Price Target on GoodRx Holdings to $5 From $6, Keeps Equalweight Rating - MarketScreener
Little Excitement Around GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Revenues As Shares Take 28% Pounding - simplywall.st
GoodRx Holdings Inc. (GDRX) PT Lowered to $5 at Morgan Stanley - StreetInsider
Goldman Sachs lowers GoodRx stock price target on healthcare headwinds By Investing.com - Investing.com Australia
Goldman Sachs lowers GoodRx stock price target on healthcare headwinds - Investing.com India
Analysts Weigh In on GoodRx Holdings (GDRX) and Arcutis Biotherapeutics (ARQT) - AInvest
GoodRx Q2 Earnings Fall Short of Expectations with EPS at 4c - AInvest
Forecasting GoodRx Holdings Inc. price range with options dataTechnical Chart Summary for Momentum Stocks - Newser
GoodRx Holdings Inc. (GDRX) PT Lowered to $3.75 at Goldman Sachs - StreetInsider
GoodRx (NASDAQ:GDRX) Hits New 1-Year Low After Earnings Miss - Defense World
GoodRx Holdings Inc (GDRX) Q2 2025 Earnings Call Highlights: Str - GuruFocus
GoodRx Reports Steady Q2 2025 Financial Results - TipRanks
GoodRx Holdings, Inc. (GDRX) Q2 Earnings and Revenues Lag Estimates - MSN
Compared to Estimates, GoodRx (GDRX) Q2 Earnings: A Look at Key Metrics - MSN
GoodRx Misses Forecasts But Sees Growth Ahead In 2025 - Finimize
GoodRx Misses Targets But Pharma Unit Powers Growth - Finimize
Goodrx stock hits 52-week low at $3.67 By Investing.com - Investing.com South Africa
Goodrx stock hits 52-week low at $3.67 - Investing.com
GoodRx Holdings Inc (GDRX) Q2 2025 Earnings Call Highlights: Strategic Growth Amidst Challenges By GuruFocus - Investing.com Canada
Goodrx Holdings Inc (GDRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Goodrx Holdings Inc 주식 (GDRX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Spectrum Equity VII, L.P. | 10% Owner |
Jul 03 '25 |
Sale |
4.80 |
10,677 |
51,226 |
0 |
2.70%
7.48%
자본화:
|
볼륨(24시간):